Report Detail
Global Orexin Receptor Type 2 Market Insights, Forecast to 2025
- RnM2989591 |
- 20 February, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
The global Orexin Receptor Type 2 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Orexin Receptor Type 2 market based on company, product type, end user and key regions.
This report studies the global market size of Orexin Receptor Type 2 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Orexin Receptor Type 2 in these regions.
This research report categorizes the global Orexin Receptor Type 2 market by top players/brands, region, type and end user. This report also studies the global Orexin Receptor Type 2 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group
Market size by Product
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others
Market size by End User
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Orexin Receptor Type 2 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Orexin Receptor Type 2 market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Orexin Receptor Type 2 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Orexin Receptor Type 2 submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Orexin Receptor Type 2 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Orexin Receptor Type 2 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Orexin Receptor Type 2 Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Orexin Receptor Type 2 Market Size Growth Rate by Product
- 1.4.2 HTL-6641
- 1.4.3 MK-8133
- 1.4.4 Lemborexant
- 1.4.5 OPN-021
- 1.4.6 YNT-185
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Orexin Receptor Type 2 Market Size Growth Rate by End User
- 1.5.2 Insomnia
- 1.5.3 Narcolepsy
- 1.5.4 Sleep Disorders
- 1.5.5 Major Depressive Disorder
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Orexin Receptor Type 2 Market Size
- 2.1.1 Global Orexin Receptor Type 2 Revenue 2014-2025
- 2.1.2 Global Orexin Receptor Type 2 Sales 2014-2025
- 2.2 Orexin Receptor Type 2 Growth Rate by Regions
- 2.2.1 Global Orexin Receptor Type 2 Sales by Regions
- 2.2.2 Global Orexin Receptor Type 2 Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Orexin Receptor Type 2 Sales by Manufacturers
- 3.1.1 Orexin Receptor Type 2 Sales by Manufacturers
- 3.1.2 Orexin Receptor Type 2 Sales Market Share by Manufacturers
- 3.1.3 Global Orexin Receptor Type 2 Market Concentration Ratio (CR5 and HHI)
- 3.2 Orexin Receptor Type 2 Revenue by Manufacturers
- 3.2.1 Orexin Receptor Type 2 Revenue by Manufacturers (2014-2019)
- 3.2.2 Orexin Receptor Type 2 Revenue Share by Manufacturers (2014-2019)
- 3.3 Orexin Receptor Type 2 Price by Manufacturers
- 3.4 Orexin Receptor Type 2 Manufacturing Base Distribution, Product Types
- 3.4.1 Orexin Receptor Type 2 Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Orexin Receptor Type 2 Product Type
- 3.4.3 Date of International Manufacturers Enter into Orexin Receptor Type 2 Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Orexin Receptor Type 2 Sales by Product
- 4.2 Global Orexin Receptor Type 2 Revenue by Product
- 4.3 Orexin Receptor Type 2 Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Orexin Receptor Type 2 Breakdown Data by End User
6 North America
- 6.1 North America Orexin Receptor Type 2 by Countries
- 6.1.1 North America Orexin Receptor Type 2 Sales by Countries
- 6.1.2 North America Orexin Receptor Type 2 Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Orexin Receptor Type 2 by Product
- 6.3 North America Orexin Receptor Type 2 by End User
7 Europe
- 7.1 Europe Orexin Receptor Type 2 by Countries
- 7.1.1 Europe Orexin Receptor Type 2 Sales by Countries
- 7.1.2 Europe Orexin Receptor Type 2 Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Orexin Receptor Type 2 by Product
- 7.3 Europe Orexin Receptor Type 2 by End User
8 Asia Pacific
- 8.1 Asia Pacific Orexin Receptor Type 2 by Countries
- 8.1.1 Asia Pacific Orexin Receptor Type 2 Sales by Countries
- 8.1.2 Asia Pacific Orexin Receptor Type 2 Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Orexin Receptor Type 2 by Product
- 8.3 Asia Pacific Orexin Receptor Type 2 by End User
9 Central & South America
- 9.1 Central & South America Orexin Receptor Type 2 by Countries
- 9.1.1 Central & South America Orexin Receptor Type 2 Sales by Countries
- 9.1.2 Central & South America Orexin Receptor Type 2 Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Orexin Receptor Type 2 by Product
- 9.3 Central & South America Orexin Receptor Type 2 by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Orexin Receptor Type 2 by Countries
- 10.1.1 Middle East and Africa Orexin Receptor Type 2 Sales by Countries
- 10.1.2 Middle East and Africa Orexin Receptor Type 2 Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Orexin Receptor Type 2 by Product
- 10.3 Middle East and Africa Orexin Receptor Type 2 by End User
11 Company Profiles
- 11.1 Actelion Pharmaceuticals Ltd
- 11.1.1 Actelion Pharmaceuticals Ltd Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Products Offered
- 11.1.5 Actelion Pharmaceuticals Ltd Recent Development
- 11.2 Eisai Co Ltd
- 11.2.1 Eisai Co Ltd Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Eisai Co Ltd Orexin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Eisai Co Ltd Orexin Receptor Type 2 Products Offered
- 11.2.5 Eisai Co Ltd Recent Development
- 11.3 Evotec AG
- 11.3.1 Evotec AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Evotec AG Orexin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Evotec AG Orexin Receptor Type 2 Products Offered
- 11.3.5 Evotec AG Recent Development
- 11.4 Heptares Therapeutics Ltd
- 11.4.1 Heptares Therapeutics Ltd Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Heptares Therapeutics Ltd Orexin Receptor Type 2 Products Offered
- 11.4.5 Heptares Therapeutics Ltd Recent Development
- 11.5 Idorsia Ltd
- 11.5.1 Idorsia Ltd Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Idorsia Ltd Orexin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Idorsia Ltd Orexin Receptor Type 2 Products Offered
- 11.5.5 Idorsia Ltd Recent Development
- 11.6 Johnson & Johnson
- 11.6.1 Johnson & Johnson Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Johnson & Johnson Orexin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Johnson & Johnson Orexin Receptor Type 2 Products Offered
- 11.6.5 Johnson & Johnson Recent Development
- 11.7 Merck & Co Inc
- 11.7.1 Merck & Co Inc Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Merck & Co Inc Orexin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Merck & Co Inc Orexin Receptor Type 2 Products Offered
- 11.7.5 Merck & Co Inc Recent Development
- 11.8 OptiNose US Inc
- 11.8.1 OptiNose US Inc Company Details
- 11.8.2 Company Business Overview
- 11.8.3 OptiNose US Inc Orexin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 OptiNose US Inc Orexin Receptor Type 2 Products Offered
- 11.8.5 OptiNose US Inc Recent Development
- 11.9 Yangtze River Pharmaceutical Group
- 11.9.1 Yangtze River Pharmaceutical Group Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Products Offered
- 11.9.5 Yangtze River Pharmaceutical Group Recent Development
12 Future Forecast
- 12.1 Orexin Receptor Type 2 Market Forecast by Regions
- 12.1.1 Global Orexin Receptor Type 2 Sales Forecast by Regions 2019-2025
- 12.1.2 Global Orexin Receptor Type 2 Revenue Forecast by Regions 2019-2025
- 12.2 Orexin Receptor Type 2 Market Forecast by Product
- 12.2.1 Global Orexin Receptor Type 2 Sales Forecast by Product 2019-2025
- 12.2.2 Global Orexin Receptor Type 2 Revenue Forecast by Product 2019-2025
- 12.3 Orexin Receptor Type 2 Market Forecast by End User
- 12.4 North America Orexin Receptor Type 2 Forecast
- 12.5 Europe Orexin Receptor Type 2 Forecast
- 12.6 Asia Pacific Orexin Receptor Type 2 Forecast
- 12.7 Central & South America Orexin Receptor Type 2 Forecast
- 12.8 Middle East and Africa Orexin Receptor Type 2 Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Orexin Receptor Type 2 Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Orexin Receptor Type 2 . Industry analysis & Market Report on Orexin Receptor Type 2 is a syndicated market report, published as Global Orexin Receptor Type 2 Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Orexin Receptor Type 2 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
